TEJARA CAPITAL LTD
Q4 2024 Form 13-F
LONDON
CIK 0001879713
· CRD 322838
· Exempt reporting adviser
$152.6M Reported Value Total
TEJARA CAPITAL LIMITED reports under management (AUM).
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Exempt Reporting Adviser
tejaracapital.com
Source: Form ADV filed 2026-08-13
Reported value
$152.6M
Quarter over quarter
-4.8%
Holdings
53
Top-10 concentration
54.3%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Teresa Hough
Compliance Analyst
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2024 13F record
Q4 2024 13F filing summary
| Period of report | December 31, 2024 |
|---|---|
| Filed | February 10, 2025 |
| Form | 13F-HR |
| Reported value | $152.6M |
| Positions | 53 |
| Change in reported value | -27.3% |
| New positions | 18 |
| Exited positions | 19 |
| Position turnover | 51.4% |
| Top-10 concentration | 54.3% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 9, 2026
|
59 | $204.6M |
|
Q2 2026 13F
Filed Aug 11, 2026
|
66 | $243.3M |
|
Q1 2026 13F
Filed May 12, 2026
|
73 | $303.4M |
|
Q4 2025 13F
Filed Feb 5, 2026
|
61 | $424.8M |
|
Q3 2025 13F
Filed Nov 4, 2025
|
46 | $191.7M |
|
Q2 2025 13F
Filed Aug 13, 2025
|
70 | $215.7M |
|
Q1 2025 13F
Filed May 13, 2025
|
74 | $259.2M |
|
Q4 2024 13F
Filed Feb 10, 2025
|
53 | $152.6M |
|
Q3 2024 13F
Filed Nov 13, 2024
|
54 | $209.9M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
67 | $275.1M |
|
Q1 2024 13F
Filed May 14, 2024
|
72 | $272.1M |
|
Q4 2023 13F
Filed Feb 12, 2024
|
67 | $238.7M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
63 | $176.4M |
|
Q2 2023 13F
Filed Aug 11, 2023
|
69 | $203.2M |
|
Q1 2023 13F
Filed May 12, 2023
|
81 | $195.4M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
93 | $173.5M |
Top 20 holdings · Q4 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | ARQT ARCUTIS BIOTHERAPEUTICS INC | $12.4M | 8.09% |
| 2 | ROIV ROIVANT SCIENCES LTD | $9.6M | 6.3% |
| 3 | BORR BORR DRILLING LTD | $8.4M | 5.51% |
| 4 | NOV NOV INC | $8.4M | 5.47% |
| 5 | MREO MEREO BIOPHARMA GROUP PLC | $8.1M | 5.31% |
| 6 | OXY OCCIDENTAL PETE CORP | $8.1M | 5.31% |
| 7 | RIG TRANSOCEAN LTD | $7.2M | 4.7% |
| 8 | HRTX HERON THERAPEUTICS INC | $7.1M | 4.67% |
| 9 | NBR NABORS INDUSTRIES LTD | $6.9M | 4.51% |
| 10 | NE NOBLE CORP PLC | $6.8M | 4.45% |
| 11 | REKR REKOR SYSTEMS INC | $5.6M | 3.69% |
| 12 | NVDA NVIDIA CORPORATION | $5.0M | 3.29% |
| 13 | VAL VALARIS LTD | $5.0M | 3.26% |
| 14 | CRDL CARDIOL THERAPEUTICS INC | $4.0M | 2.61% |
| 15 | SLB SCHLUMBERGER LTD | $3.8M | 2.52% |
| 16 | NESR NATIONAL ENERGY SERVICES REU | $3.6M | 2.36% |
| 17 | FET FORUM ENERGY TECHNOLOGIES IN | $3.6M | 2.34% |
| 18 | BIDU BAIDU INC | $2.3M | 1.53% |
| 19 | SCPH SCPHARMACEUTICALS INC | $2.2M | 1.42% |
| 20 | TDW TIDEWATER INC NEW | $2.2M | 1.42% |
Values as reported on the Q4 2024 Form 13F. Every position is in the holdings table below.